News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Whitcup Scott M
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/14/2021 |
4
| Whitcup Scott M (Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 40,000 options to buy
@ $3.7, valued at
$148k
|
|
| 06/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2020 |
4
| Whitcup Scott M (Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 60,000 options to buy
@ $11.62, valued at
$697.2k
|
|
| 04/20/2020 |
3
| Whitcup Scott M (Director) has filed a Form 3 on Adverum Biotechnologies, Inc. |
| 08/08/2019 |
4/A
| Whitcup Scott M (Director) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Granted 22,500 options
@ $6.02, valued at
$135.5k
|
|
| 06/27/2019 |
4
| Whitcup Scott M (Director) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Granted 22,500 options
@ $6.02, valued at
$135.5k
|
|
| 06/07/2019 |
4
| Whitcup Scott M (Director) has filed a Form 4 on Nightstar Therapeutics plc|
Txns:
| Disposed/sold 74,568 shares
@ $25.5, valued at
$1.9M
Disposed/sold 18,200 options to buy
@ $12.27, valued at
$223.3k
Disposed/sold 21,000 options to buy
@ $13.57, valued at
$285k
|
|
| 01/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2019 |
4
| Whitcup Scott M (Director) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Exercised 25,000 options
@ $1.8343, valued at
$45.9k
|
|
| 01/02/2019 |
3
| Whitcup Scott M (Director) has filed a Form 3 on Nightstar Therapeutics plc |
| 01/24/2018 |
3
| Whitcup Scott M (Director) has filed a Form 3 on Menlo Therapeutics, Inc. |
| 03/19/2015 |
4
| Whitcup Scott M (Executive VP, R&D, CSO) has filed a Form 4 on ALLERGAN INC|
Txns:
| Gifted 9,766 shares
@ $0
Granted 11,274 shares
@ $0
Disposed/sold 18,683 shares
@ $0
Disposed/sold 1,739 shares
@ $0
Disposed/sold 1,710 shares
@ $0
Disposed/sold 89,200 options to buy
@ $58.55, valued at
$5.2M
Disposed/sold 105,500 options to buy
@ $64.47, valued at
$6.8M
Disposed/sold 130,400 options to buy
@ $40.16, valued at
$5.2M
Disposed/sold 92,600 options to buy
@ $59.13, valued at
$5.5M
Disposed/sold 120,000 options to buy
@ $75.58, valued at
$9.1M
Disposed/sold 60,000 options to buy
@ $105.87, valued at
$6.4M
|
|
| 02/24/2015 |
4
| Whitcup Scott M (Executive VP, R&D, CSO) has filed a Form 4 on ALLERGAN INC|
Txns:
| Paid exercise price by delivering 80 shares
@ $234, valued at
$18.7k
Granted 212 restricted stock units
@ $0
Exercised 212 restricted stock units
@ $0 |
|
| 08/18/2014 |
4
| Whitcup Scott M (Director) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC|
Txns:
| Disposed/sold 4,183 shares
@ $0
Disposed/sold 13,530 options to buy
@ $35.78, valued at
$484.1k
Disposed/sold 3,803 options to buy
@ $40.37, valued at
$153.5k
Disposed/sold 9,203 options to buy
@ $34.86, valued at
$320.8k
|
|
| 02/25/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/19/2014 |
4
| Whitcup Scott M (Executive VP, R&D, CSO) has filed a Form 4 on ALLERGAN INC|
Txns:
| Paid exercise price by delivering 284 shares
@ $124.57, valued at
$35.4k
|
|
| 01/15/2014 |
4
| Whitcup Scott M (Executive VP, R&D, CSO) has filed a Form 4 on ALLERGAN INC|
Txns:
| Sold 21,000 shares
@ $116.8, valued at
$2.5M
Sold 21,000 shares
@ $118.8, valued at
$2.5M
Exercised 42,000 options to buy
@ $55.975, valued at
$2.4M
|
|
| 01/10/2014 |
4
| Whitcup Scott M (Executive VP, R&D, CSO) has filed a Form 4 on ALLERGAN INC|
Txns:
| Sold 21,000 shares
@ $112.8, valued at
$2.4M
Sold 21,000 shares
@ $114.8, valued at
$2.4M
Exercised 42,000 options to buy
@ $55.975, valued at
$2.4M
|
|
| 01/07/2014 |
4/A
| Whitcup Scott M (Executive VP, R&D, CSO) has filed a Form 4 on ALLERGAN INC|
Txns:
| Sold 24,200 shares
@ $111.8, valued at
$2.7M
Exercised 24,200 options to buy
@ $36.15, valued at
$874.8k
|
|
| 01/06/2014 |
4
| Whitcup Scott M (Executive VP, R&D, CSO) has filed a Form 4 on ALLERGAN INC|
Txns:
| Exercised 16,500 shares
@ $0
Sold 16,500 shares
@ $107.8, valued at
$1.8M
Sold 16,500 shares
@ $109.8, valued at
$1.8M
Exercised 16,500 options to buy
@ $36.15, valued at
$596.5k
|
|
| 12/20/2013 |
4
| Whitcup Scott M (Executive VP, R&D, CSO) has filed a Form 4 on ALLERGAN INC|
Txns:
| Sold 16,500 shares
@ $107.8, valued at
$1.8M
Sold 16,500 shares
@ $109.8, valued at
$1.8M
Exercised 16,500 options to buy
@ $36.15, valued at
$596.5k
|
|
| 05/29/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/27/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/25/2013 |
4
| Whitcup Scott M (Executive VP, R&D, CSO) has filed a Form 4 on ALLERGAN INC|
Txns:
| Sold 1,191 shares
@ $112, valued at
$133.4k
Sold 4,925 shares
@ $112, valued at
$551.6k
Exercised 1,191 options to buy
@ $36.15, valued at
$43.1k
Exercised 4,925 options to buy
@ $36.15, valued at
$178k
Sold 1,191 shares
@ $112, valued at
$133.4k
Sold 4,925 shares
@ $112, valued at
$551.6k
Exercised 1,191 options to buy
@ $36.15, valued at
$43.1k
Exercised 4,925 options to buy
@ $36.15, valued at
$178k
|
|
| 02/22/2013 |
4
| Whitcup Scott M (Executive VP, R&D, CSO) has filed a Form 4 on ALLERGAN INC|
Txns:
| Paid exercise price by delivering 5,218 shares
@ $108.08, valued at
$564k
Granted 60,000 options to buy
@ $105.87, valued at
$6.4M
|
|
| 02/20/2013 |
4
| Whitcup Scott M (Executive VP, R&D, CSO) has filed a Form 4 on ALLERGAN INC|
Txns:
| Paid exercise price by delivering 434 shares
@ $108.02, valued at
$46.9k
|
|
| 02/19/2013 |
4
| Whitcup Scott M (Director) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.|
Txns:
| Granted 38,900 shares
@ $0 |
|
| 01/07/2013 |
4
| Whitcup Scott M (Executive VP, R&D, CSO) has filed a Form 4 on ALLERGAN INC|
Txns:
| Sold 24,000 shares
@ $96.8, valued at
$2.3M
Exercised 24,000 options to buy
@ $41.24, valued at
$989.8k
|
|
| 12/11/2012 |
4
| Whitcup Scott M (Executive VP, R&D, CSO) has filed a Form 4 on ALLERGAN INC|
Txns:
| Sold 6,800 shares
@ $91.234, valued at
$620.4k
Exercised 6,800 options to buy
@ $30.125, valued at
$204.9k
|
|
| 10/18/2012 |
4
| Whitcup Scott M (Executive VP, R&D, CSO) has filed a Form 4 on ALLERGAN INC|
Txns:
| Sold 5,000 shares
@ $94.7, valued at
$473.5k
Exercised 5,000 options to buy
@ $30.125, valued at
$150.6k
|
|
| 10/02/2012 |
4
| Whitcup Scott M (Executive VP, R&D, CSO) has filed a Form 4 on ALLERGAN INC|
Txns:
| Sold 6,000 shares
@ $92.7, valued at
$556.2k
Exercised 6,000 options to buy
@ $30.125, valued at
$180.8k
|
|
| 05/31/2012 |
4
| Whitcup Scott M (Executive VP, R&D, CSO) has filed a Form 4 on ALLERGAN INC|
Txns:
| Sold 1,500 shares
@ $90.7079, valued at
$136.1k
Exercised 1,500 options to buy
@ $30.125, valued at
$45.2k
|
|
| 05/18/2012 |
4
| Whitcup Scott M (Executive VP, R&D, CSO) has filed a Form 4 on ALLERGAN INC|
Txns:
| Sold 1,500 shares
@ $92, valued at
$138k
Exercised 1,500 options to buy
@ $30.125, valued at
$45.2k
|
|
|
|
|